ATE105188T1 - Reinigung von pertussis-toxinen und herstellung von vakzine. - Google Patents

Reinigung von pertussis-toxinen und herstellung von vakzine.

Info

Publication number
ATE105188T1
ATE105188T1 AT8989303369T AT89303369T ATE105188T1 AT E105188 T1 ATE105188 T1 AT E105188T1 AT 8989303369 T AT8989303369 T AT 8989303369T AT 89303369 T AT89303369 T AT 89303369T AT E105188 T1 ATE105188 T1 AT E105188T1
Authority
AT
Austria
Prior art keywords
fha
lpf
medium
purified
adsorbing
Prior art date
Application number
AT8989303369T
Other languages
English (en)
Inventor
Larry U L Tan
Gail Jackson
Dirk Alkema
Po S Wah
Rafaat Emil Fahmy Fahim
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Application granted granted Critical
Publication of ATE105188T1 publication Critical patent/ATE105188T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
AT8989303369T 1988-04-05 1989-04-05 Reinigung von pertussis-toxinen und herstellung von vakzine. ATE105188T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888807860A GB8807860D0 (en) 1988-04-05 1988-04-05 Pertussis vaccine
EP89303369A EP0336736B1 (de) 1988-04-05 1989-04-05 Reinigung von Pertussis-Toxinen und Herstellung von Vakzine

Publications (1)

Publication Number Publication Date
ATE105188T1 true ATE105188T1 (de) 1994-05-15

Family

ID=10634535

Family Applications (1)

Application Number Title Priority Date Filing Date
AT8989303369T ATE105188T1 (de) 1988-04-05 1989-04-05 Reinigung von pertussis-toxinen und herstellung von vakzine.

Country Status (8)

Country Link
US (1) US4997915A (de)
EP (1) EP0336736B1 (de)
JP (1) JPH0789949B2 (de)
AT (1) ATE105188T1 (de)
CA (1) CA1331134C (de)
DE (1) DE68915045T2 (de)
ES (1) ES2052909T3 (de)
GB (1) GB8807860D0 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US5191197A (en) * 1988-05-11 1993-03-02 Symbol Technologies, Inc. Arm mounted scanner actuatable by hand movement
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5391715A (en) * 1989-11-06 1995-02-21 Smithkline Beecham Biologicals Method for isolating and purifying bordetella pertussis antigenic factors
US5578308A (en) * 1990-02-12 1996-11-26 Capiau; Carine Glutaraldehyde and formalin detoxified bordetella toxin vaccine
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
IL97985A0 (en) * 1990-05-07 1992-06-21 North American Vaccine Inc Improved vaccine compositions
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
GB9021004D0 (en) * 1990-09-27 1990-11-07 Wellcome Found Acellular vaccines
US6444211B2 (en) 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
US5932217A (en) * 1991-05-03 1999-08-03 The Rockefeller University Peptides which inhibit adhesion between leukocytes and endothelial cells
GB9115332D0 (en) * 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
ATE183194T1 (de) * 1994-04-28 1999-08-15 Takeda Chemical Industries Ltd Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US6696065B1 (en) * 1995-05-04 2004-02-24 Aventis Pastuer Limited Acellular pertussis vaccines and methods of preparation thereof
NZ306392A (en) 1995-05-04 1999-04-29 Connaught Lab Acellular pertussisvaccines, fimbrial agglutinogin preparation prepared from bordetella strain preparation
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
ATE339965T1 (de) 1996-07-02 2006-10-15 Aventis Pasteur Vielwertige dtp-polio-impfstoffe
AU2232399A (en) * 1998-01-16 1999-08-02 Maxim Pharmaceuticals, Inc. Recombinant ctb-based vaccines
ES2781475T3 (es) 2002-09-18 2020-09-02 Janssen Pharmaceuticals Inc Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
NZ541969A (en) * 2003-03-13 2008-01-31 Glaxosmithkline Biolog Sa Purifying pneumolysin from Streptococcus pneumoniae in a single chromatographic step by binding it to a hydrophobic interaction column in the presence of detergent and high salt
CA2542593A1 (en) * 2003-10-14 2005-04-21 Kingston Henry Gordon Mills Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders
US8299210B2 (en) * 2003-11-20 2012-10-30 Sanofi Pasteur Methods for purifying pertussis toxin and peptides useful therefor
EP1765394B1 (de) 2004-06-04 2009-08-05 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES Verfahren zur herstellung von immunogenen konjugaten
DE602008004747D1 (de) * 2007-02-22 2011-03-10 Baxter Int Verfahren zur aufreinigung hydrophober proteine
US20080306610A1 (en) * 2007-06-07 2008-12-11 Zimmer Orthobiologics, Inc. Tissue processing for nonimmunogenic implants
EP2430040A1 (de) 2009-05-11 2012-03-21 Novartis AG Antigenaufreinigungs­verfahren für pertactinantigen
US8435305B2 (en) 2010-08-31 2013-05-07 Zimmer, Inc. Osteochondral graft delivery device and uses thereof
US20140234360A1 (en) 2011-09-30 2014-08-21 The United States of America, as represented by the Secretary, Dept.of Health and Human Services Influenza vaccine
MY172181A (en) 2013-03-08 2019-11-15 Janssen Vaccines & Prevention Bv Acellular pertussis vaccine
EP3518968B1 (de) 2016-10-03 2022-01-05 The U.S.A. as represented by the Secretary, Department of Health and Human Services Hiv-1-env-fusionspeptid-immunogene und deren verwendung
WO2018081832A1 (en) 2016-10-31 2018-05-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Peptide fragments from filoviruses and their uses
US11235056B2 (en) 2017-03-24 2022-02-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Glycan-masked engineered outer domains of HIV-1 gp120 and their use
EP3697440A1 (de) 2017-10-16 2020-08-26 The United States of America, as represented by the Secretary, Department of Health and Human Services Rekombinante hiv-1-hüllproteine und deren verwendung
WO2020061564A1 (en) 2018-09-23 2020-03-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hiv-1 env fusion peptide nanoparticle carrier conjugates and their use
WO2020086483A1 (en) 2018-10-22 2020-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant gp120 protein with v1-loop deletion
CA3228275A1 (en) 2021-08-03 2023-02-09 Genoveffa Franchini Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infection
WO2023192835A1 (en) 2022-03-27 2023-10-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Base-covered hiv-1 envelope ectodomains and their use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
US4563303A (en) * 1984-04-14 1986-01-07 Judicial Foundation The Chemosero-Therapeutic Research Institute Method for purification of filamentous hemagglutinin
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4705686A (en) * 1986-05-09 1987-11-10 American Cyanamid Process for the preparation of acellular Bordetalla pertussis vaccine
FR2601250B1 (fr) * 1986-07-08 1989-12-01 Pasteur Institut Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la coqueluche contenant de telles fractions.

Also Published As

Publication number Publication date
EP0336736A1 (de) 1989-10-11
GB8807860D0 (en) 1988-05-05
JPH0231689A (ja) 1990-02-01
DE68915045T2 (de) 1994-08-25
CA1331134C (en) 1994-08-02
DE68915045D1 (de) 1994-06-09
US4997915A (en) 1991-03-05
EP0336736B1 (de) 1994-05-04
JPH0789949B2 (ja) 1995-10-04
ES2052909T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
ATE105188T1 (de) Reinigung von pertussis-toxinen und herstellung von vakzine.
KR930016109A (ko) 안정한 피브리노겐 용액
ES2155477T3 (es) Purificacion cromatografica y procedimiento de separacion de acidos nucleicos.
DE69200465T2 (de) Reinigung von Lösungen.
CA2153010A1 (en) Filter for separating photoactive agent
KR960021108A (ko) 가스 스트림으로부터 이산화탄소를 제거하는 방법
ATE61594T1 (de) Verwendung eines adsorptionmittels zum entfernen von vinylpyrrolidon aus vinylpyrrolidon- polymerisat-loesungen.
JPS645907A (en) Ammonia separation using ion exchange high molecular membrane and absorbent
EP0729783A3 (de) Stickstoff enthaltendes Kohlenstoffmolekularsieb, Verfahren zur Herstellung und Verwendung
EP0458990A4 (en) Method of concentrating chlorine gas
ATE128958T1 (de) Behandlung von verunreinigten flüssigen strömen aus ethylenoxid/glycol-herstellungsprozessen mit semipermeablen membranen.
DK0646594T3 (da) Fremgangsmåde til rensning af proteiner
DK0431593T3 (da) Separationsmetode og separationsmiddel
DE69307701D1 (de) Verfahren zur reinigung von acetonitril
ES2159743T3 (es) Metodo para eliminar constituyentes organicos de una corriente acuosa.
DE3865570D1 (de) Absorbensmittel fuer gasreinigung und reinigungsverfahren.
DE69930443D1 (de) Verfahren zur Behandlung von verunreinigtem Fluid
DE59006652D1 (de) Verfahren zur Desorption von Adsorbentia.
JPS5756039A (en) Adsorbent for middle molecular weight protein
CA2297043A1 (en) A method to remove biguanide from an aqueous source
RU97103958A (ru) Способ концентрирования вируса
DE69116069D1 (de) Polytetraalkylammonium und Polytrialkylamin enthaltende liganden auf inorganischen Trägern gebunden und deren Anwendung zum Trennen und Konzentrieren von Ionen in Flüssigkeiten
SU1650242A1 (ru) Сорбент дл очистки растворов от аминов
JPS55147149A (en) Selective oxygen adsorbent
JPS5387400A (en) Collection of protein

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time